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Highlights
Background 
A first quality of life (QOL) study among Maltese adults with congenital heart disease (ACHD) in 2016 found no significant differences 
when compared to the general population.  The aims of the present study were to (1) compare QOL between Maltese and other 
European ACHD patients and (2) investigate medical predictors (i.e. number of surgical/non-surgical interventions, heart failure, 
arrhythmias, pacemaker/implantable cardioverter-defibrillator, cardiac hospitalisation during preceding year, follow-up frequency, 
other medical conditions, mood/anxiety/psychiatric disorders) of QOL in Maltese patients.
Methods
Data collected during “Assessment of Patterns of Patient-Reported Outcomes in Adults with Congenital Heart disease–International 
Study” (APPROACH-IS) was used.  QOL was measured using linear analog scale (LAS) and Satisfaction With Life Scale (SWLS).  QOL 
in 109 Maltese and 1510 European participants was compared.  Multivariable logistic regression was used to test the predictive value 
of medical factors on QOL in Maltese patients.
Results 
There were no significant differences in QOL between the two cohorts [mean LAS Malta 80.51 (95% CI 77.96,83.07) vs. European 
79.43 (95% CI 78.65,80.21) (p=0.776); mean SWLS Malta 26.00 (95% CI 24.94,27.06) vs. European 26.26 (95% CI 25.95,26.57) 
(p=0.288)] and no significant differences when cohorts were divided by gender and age.  Only a mood/anxiety/other psychiatric 
disorder significantly predicted poorer QOL on both scales in Maltese patients (LAS (ß=-.389, p<0.001), SWLS (ß=-.352, p=0.001)).  
ISSN: 2410-2636
© 2017 Author(s). This is an Open Access article distributed under the terms of the Creative Commons Attribution CC-BY-4.0 license (http://creativecommons.org/licenses/
by/4.0/), which permits use, distribution and reproduction, provided the original work is properly cited. Published by Barcaray (International) Publishing.
Original Article | 19International Cardiovascular Forum Journal 12 (2017)DOI: 10.17987/icfj.v12i0.465
INTRODUCTION
With the majority of patients born with congenital heart disease 
(CHD) nowadays surviving into adulthood [1,2], there has been 
increasing interest in the study of quality of life (QOL) in adults 
with congenital heart disease (ACHD) [3,4]. An initial QOL 
study in Maltese ACHD patients used vitality and mental health 
questionnaires from the 36-item short-form health survey (SF-
36), which had previously been applied to the general Maltese 
population during the 2008 European Health Interview Survey 
[5].  This study found no significant differences in QOL between 
ACHD patients and age- and sex-matched general Maltese 
subjects, and identified hospitalisation within the previous twelve 
months as the only clinical factor out of the ones studied to bear 
a significant negative impact on QOL in the patient cohort [5]. 
The present study utilises data from the large multi-centre 
collaboration “Assessment of Patterns of Patient-Reported 
Outcomes in Adults with Congenital Heart disease – International 
Study” (APPROACH-IS) [6,7] in which Malta was a participating 
centre, in order to gain further insight into QOL among Maltese 
ACHD patients.  The aims were: (a) to compare QOL in Maltese 
ACHD patients with ACHD patients in other participating 
European countries, and (b) to investigate the role of several 
medical factors as predictors of QOL among Maltese patients. 
METHODS
Study protocol
APPROACH-IS is a cross-sectional study conducted in 
partnership with the International Society of Adult Congenital 
Heart Disease (ISACHD).  Data was collected from 15 countries 
from 5 continents between April 2013 and March 2015 using self-
reporting questionnaires administered in person or sent by mail 
to eligible ACHD patients.  Inclusion criteria were: (a) diagnosis 
of CHD before the age of 10 years, (b) age 18 years or older 
at enrolment (c) ongoing follow-up in a CHD centre or included 
in a national/regional database and (d) being in possession of 
physical, cognitive and language capabilities to answer the 
self-reporting questionnaires.  Full details of rationale, design 
and methods have been previously published [6].  In Malta, the 
English language version of the questionnaires was used due to 
lack of availability of questionnaires appropriately translated to 
the Maltese language.  These were sent by surface mail to eligible 
patients extracted from the local ACHD database.  Medical 
data was obtained through review of participants’ medical 
records.  Written informed consent was obtained from each 
 
participant. Institutional review board approval was obtained 
from participating centres where required; in Malta, the study 
was given clearance by the University of Malta Research Ethics 
Committee and the Data Protection Officer at Mater Dei Hospital.
Variables and measurements
Based on thorough conceptual work [8], QOL was defined 
as “the degree of overall life satisfaction that is positively or 
negatively influenced by individuals’ perception of certain 
aspects of life important to them, including matters both related 
and unrelated to health” [9].  Following this definition, for the 
purposes of APPROACH-IS, QOL was assessed using the Linear 
Analog Scale (LAS) and the Satisfaction With Life Scale (SWLS), 
both of which have good psychometric properties when used 
with ACHD patients [10].  LAS consists of a vertically-oriented 
graded line with indicators from 0 to 100, with 0 representing 
the worst imaginable and 100 representing the best imaginable 
QOL [10].  SWLS consists of five statements each requiring a 
response of 1 (strongly disagree) to 7 (strongly agree), with total 
scores ranging from 5 to 35 [11].  An SWLS score of 20 is the 
neutral point on the scale [6].  CHD lesion severity was classified 
in accordance with the recommendations of Task Force 1 of the 
32nd Bethesda Conference [12].
The eight medical factors that were investigated for their role as 
predictors of QOL among Maltese patients were: (i) number of 
surgical or non-surgical interventions up to date of enrolment, 
(ii) congestive heart failure (CHF), (iii) arrhythmias, (iv) need 
for pacemaker or implantable cardioverter-defibrillator (ICD) 
implantation, (v) in-patient hospitalisation for cardiac reasons 
during preceding year, (vi) frequency of cardiac specialist 
follow-up, (vii) other medical (non-cardiac) conditions and (viii) 
documented mood, anxiety or other psychiatric disorders.
Statistical methods
To address the first study aim, a comparison of QOL as assessed 
by LAS and SWLS was performed between Maltese patients 
(“Maltese cohort”) and patients from all other participating 
European countries (“European cohort”); this was followed by a 
sub-analysis based on gender and age category.  Younger age 
category was defined as age ≤ 30 years and older age category 
as age > 30 years.  The 30-years age cut-off was chosen 
arbitrarily as one that generated a fair numerical split in the 
Maltese cohort.  Categorical variables were analysed using Chi-
square test, while in the case of smaller sample sizes, Fisher’s 
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Conclusions 
Maltese ACHD patients have a good QOL comparable to that of European counterparts.  Mood, anxiety and other psychiatric 
disorders can negatively impact Maltese patients’ QOL.  Better access to clinical psychology services should be ensured.
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Exact test was applied.  All numerical variables showed a non-
normal distribution on Shapiro-Wilk testing, thus non-parametric 
tests (i.e. Mann-Whitney U and Kruskal-Wallis tests) were applied 
for their analyses.
To address the second study aim, multivariable linear regression 
analysis was used to test whether the eight chosen medical 
factors significantly predicted QOL among Maltese ACHD 
patients.  In view of the small number of patients in the Maltese 
cohort, patients were grouped into two categories for each of 
the eight medical variables in order to avoid further reducing the 
sample sizes.  For this purpose, frequency of cardiac surgery 
/ interventional procedure was categorised as “up to 1” or 
“more than 1” procedure and specialist ACHD follow-up was 
categorised as “at least every 2 years” or “less often than every 
2 years”.  All analyses were performed using SPSS 21 (IBM® 
SPSS® 21, SPSS Inc., Chicago IL, USA).  Statistical significance 
was defined as p<0.05 and all tests were two-sided.
RESULTS
Participant characteristics
In Malta, 119 of the 378 eligible ACHD patients agreed to 
participate in the study, of whom 109 completed LAS and SWLS 
questionnaires and were included in current analyses (“Maltese 
cohort”).  Of the 1616 ACHD responders from the other 7 
participating European countries, LAS and SWLS questionnaires 
were completed by 1510 participants (“European cohort”): 
(Leuven, Belgium n= 268; Lyon, France n= 89; Milan, Italy n= 
59; Oslo, Norway n= 169; Sweden (Gothenburg, Stockholm, 
Umea) n= 448; Bern, Switzerland n= 232; the Netherlands 
(ConCor registry) n= 245).  Table 1 summarises the participant 
characteristics for the two study cohorts.  Maltese patients were 
significantly younger (median age 27 years vs. 34 years; p<0.001) 
while sex distribution was not significantly different between the 
two cohorts.  Differences in distribution of CHD lesion complexity 
between the 2 cohorts did not reach statistical significance. 
Moderate lesion complexity was the commonest in both cohorts 
(51.4% in Maltese cohort; 47.2% in European cohort), although 
there was a larger proportion of patients with lesions of great 
complexity in the European cohort (21.1%) when compared to 
the Maltese cohort (11.9%).
Comparison of QOL between Maltese and European 
cohorts 
There was no significant difference in QOL on either scale 
between Maltese and European participants.  Mean QOL on the 
LAS was 80.51 (95% CI 77.96, 83.07) (median 80.00) for Maltese 
patients compared to 79.43 (95% CI 78.65, 80.21) (median 
80.00) for patients in the European cohort (p=0.776).  Mean QOL 
on the SWLS was 26.00 (95% CI 24.94, 27.06) (median 28.00) for 
Maltese participants compared to 26.26 (95% CI 25.95, 26.57) 
(median 28.00) for European patients (p=0.288).  Comparisons 
based on gender and age category also demonstrated no 
significant differences in QOL on either scale (Table 2).
Medical factors as predictors of QOL in the Maltese 
ACHD cohort
The medical factors investigated among the 109 patients in the 
Maltese cohort are summarised in Table 3.  Regression analysis 
indicated that the medical predictor model explained 17.0% of 
the variance in LAS score (R2=.233, F(8,98)=3.718, p=0.001) and 
9.4% of the variance in SWLS score (R2=.163, F(8,98)=2.379, 
p=0.022).  The only factor to significantly predict QOL using either 
score was the presence of a mood, anxiety or other psychiatric 
disorder (LAS (ß = -.389, p<0.001), SWLS (ß = -.352, p=0.001)). 
More frequent specialist ACHD follow-up, defined as follow-up at 
least every 2 years, was significantly predictive of better QOL as 
measured by LAS (ß = .210, p=0.028).
DISCUSSION
Several factors in the day-to-day life of adults with congenital heart 
disease, including symptoms, frequent hospital appointments 
and need for repeat surgeries and structural cardiac interventions, 
can be expected to have a negative impact on QOL.  Findings 
of QOL research in CHD have been inconsistent, in good part 
due to differences in methodological approaches among studies 
[3]. Furthermore, it is becoming increasingly clear that medical 
factors might not be as important in contributing to QOL when 
compared to certain psychosocial factors [13,14].
In a previous study, Maltese ACHD patients showed no significant 
differences in QOL when compared to the general Maltese 
population, as assessed using vitality and mental health elements 
from the SF-36 questionnaire [5].  In the present study, Maltese 
ACHD patients also reported good QOL as measured by LAS and 
SWLS and this was not significantly different from that of patients 
from other European countries.  Indeed, Maltese participants had 
the fourth best QOL overall among all participating countries in 
the main APPROACH-IS study [7].  As per the second study aim, 
the presence of mood, anxiety or other psychiatric disorders 
was revealed to be the only medical factor to predict a poorer 
QOL as assessed by either scale among Maltese ACHD patients. 
It has been shown that ACHD patients are at increased risk of 
mood and anxiety disorders and that these conditions tend to 
be under-treated in this patient population [15].  This finding 
underlines the importance of close collaboration with clinical 
psychologists to ensure timely diagnosis and management of 
such psychiatric disorders, as well as the introduction of means 
to routinely screen for psychological difficulties from an early 
stage [16,17].  Interestingly, and contrary to expectation, more 
Table 1. Baseline characteristics of participants in the two 
study cohorts
Characteristic
Maltese 
cohort
(N=109)
European 
cohort
(N=1510) p value
Gender (n (%)) 0.372
Males 50  
(45.9)
765  
(50.7)
Females 59  
(54.1)
745  
(49.3)
Median age, years 27  
(IQR: 22-34)
34  
(IQR: 26-45)
<0.001
Lesion complexity (n (%)) 0.068
Simple 40 (36.7) 479 (31.7)
Moderate 56 (51.4) 712 (47.2)
Great 13 (11.9) 319 (21.1)
IQR = interquartile range
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frequent ACHD specialist follow-up was found to be a significant 
predictor of better QOL as assessed by LAS, though it had no 
significant predictive value on SWLS.  One explanation for this 
finding could be the establishment of a better rapport between 
ACHD specialist and patient because of more frequent clinical 
encounters, which could in turn lead to the earlier detection 
of issues that warrant psychological input.  All other chosen 
medical factors, including more frequent surgeries/interventions, 
hospital admissions and heart failure, failed to show significant 
predictive value. 
Overall, the eight medical factors studied explained only a small 
proportion of the variance in QOL among Maltese ACHD patients. 
This finding is in line with previously reported observations 
[7,13] reinforcing the notion that objective medical variables 
bear very little weight in determining QOL in ACHD patients. 
The main APPROACH-IS paper by Apers et al reported several 
social characteristics, including older age, job seeking, being 
unemployed and never having been married, as being linked 
with poorer QOL, even though these factors still explained only a 
small proportion of variability in QOL in the whole APPROACH-IS 
cohort [7].
Methodological limitations
The main limitation of this study is the small number of patients 
in the Maltese ACHD cohort, in itself an inevitable consequence 
of the small Maltese population.  Despite efforts to collapse all 
eight medical variables into two categories, 5 of the 8 medical 
predictors had very small numbers recorded and this could have 
affected the result of multivariable logistic regression analysis. 
Maltese ACHD participants were significantly younger compared 
to those in the European cohort and this could have affected 
the outcome of QOL comparison analysis.  This is particularly 
relevant in light of findings reported in the main APPROACH-IS 
paper where older age was one element linked with poorer QOL 
[7].  However, in the present study, comparison of QOL by age 
category failed to demonstrate a significant difference between 
the two cohorts.
CONCLUSIONS
Maltese ACHD patients have a very good QOL, which is on 
par with that of their European counterparts. Though thorough 
specialist long-term follow-up remains imperative to ensure 
good clinical outcomes, most medical factors appear not to 
bear as much weight in determining QOL as one might expect. 
The presence of mood, anxiety and other psychiatric disorders 
Table 2. Comparison of quality of life (QOL) on the Linear 
Analog Scale (LAS) and Satisfaction With Life Scale (SWLS) 
between ACHD patients in the Maltese and European cohorts, 
divided by gender and by age group
QOL Male participants p 
value
Maltese (n=50) European (n=765)
LAS 80.36  
(95% CI 76.82, 83.90)
(80.00)
80.29  
(95% CI 79.22, 81.36)
(80.00)
0.640
SWLS 25.88  
(95% CI 24.35,27.41)
(27.00)
26.16  
(95% CI 25.73,26.60)
(28.00)
0.361
Female participants
Maltese (n=59) European (n=745)
LAS 80.64  
(95% CI 76.91, 84.38)
(80.00)
78.52  
(95% CI 77.39, 79.65)
(80.00)
0.383
SWLS 26.10  
(95% CI 24.60, 27.60)
(28.00)
26.35  
(95% CI 25.90, 26.79)
(28.00)
0.536
Younger age category participants (≤ 30 years of age)
Maltese (n=65) European (n=572)
LAS 81.18  
(95% CI 78.07, 84.29)
(80.00)
81.17  
(95% CI 79.97, 82.36)
(83.00)
0.695
SWLS 26.03  
(95% CI 24.64, 27.42)
(28.00)
26.29  
(95% CI 25.80, 26.78)
(28.00)
0.471
Older age category participants (> 30 years of age)
Maltese (n=44) European (n=936)
LAS 79.52  
(95% CI 75.03, 84.02)
(80.00)
78.40  
(95% CI 77.39, 79.42)
(80.00)
0.796
SWLS 25.95 (95% CI 24.25, 
27.66)
(28.00)
26.25  
(95% CI 25.85, 26.65)
(28.00)
0.437
QOL on both scales is expressed as mean (95% CI) followed 
by median
Table 3. Medical factors investigated as QOL predictors 
among Maltese ACHD patients (N=109)
Medical factor n (%) LAS SWLS
ß p value ß p value
> 1 cardiac surgery 
/ interventional 
procedure
82  
(75.2)
.087 0.349 -.064 0.511
Documented 
congestive heart 
failure
3  
(2.8)
.123 0.241 .023 0.835
Documented 
arrhythmias
9  
(8.3)
.101 0.441 .125 0.360
Permanent pacemaker/ 
implantable cardioverter-
defibrillator
3  
(2.8)
-.115 0.317 -.056 0.642
In-patient cardiac 
admissions in 
previous year
6  
(5.5)
-.015 0.892 -.011 0.923
Other medical 
conditions
51  
(46.8)
-.130 0.154 .027 0.777
Specialist ACHD 
follow-up at least 
every 2 years
54  
(49.5)
.210 0.028 .133 0.178
Documented mood 
/ anxiety / other 
psychiatric disorder
6  
(5.5)
-.389 <0.001 -.352 0.001
The presence of a mood, anxiety or other psychiatric disorder 
was the only significant predictor of QOL on both scores. More 
regular follow-up was predictive of better QOL as assessed 
by LAS.
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appears to play an important role in determining QOL in the 
Maltese patient population and, thus, more efforts should be 
made to facilitate access to clinical psychologists through clearer 
referral pathways to ensure earlier diagnosis and treatment of 
these disorders.
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